MedTrace Logo

Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity

NCT03755973 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-06-01

No results posted yet for this study

Summary

This study will assess the change in endometrial gene expression signature on the day of embryo transfer according to the type of exogenous gonadotropins administered.

Conditions

  • Infertility, Female
  • Endometrial Diseases

Interventions

DRUG

CFA

Long-acting exogenous ovarian stimulation

DRUG

rFSH

Daily rFSH

PROCEDURE

Fixed daily rFSH dosing protocol of 200-300 IU

The dose of daily rFSH is fixed at 200 or 300 IU

PROCEDURE

Step-down daily rFSH dose

The dose of daily rFSH is progressively reduced

Sponsors & Collaborators

Principal Investigators

  • Samuel Santos-Ribeiro, MD PhD · Instutito Valenciano de Infertilidade de Lisboa

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-29
Primary Completion
2023-05-22
Completion
2023-05-22

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03755973 on ClinicalTrials.gov